Reach Us +44-3308187254


The Knowledge And Attitude Of The Health Professionals Towards Pharmacovigilance And Adverse Drug Reaction Reporting | 13349
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

The knowledge and attitude of the health professionals towards pharmacovigilance and adverse drug reaction reporting

International Summit on Clinical Pharmacy & Dispensing

Hale Zerrin Toklu, Mertdogan Soyalan, R?meysa Demirdamar, Mehmet ?zpolat, Onur G?ltekin and Meryem Deniz Aydın

Accepted Abstracts: Clinic Pharmacol Biopharmaceut

DOI: 10.4172/2167-065X.S1.004

Background: Adverse drug reactions (ADR) are ranked as one of the major cause of patient morbidity and mortality. Spontaneous reporting of ADRs has remained the cornerstone of pharmacovigilance and is important in maintaining patient safety. Therefore, we aimed to assess knowledge and attitude of the health professionals towards pharmacovigilance and ADR reporting. Methods: A face to face questionnaire was conducted with 90 community pharmacists, 98 nurses and 70 physicians in Turkish Republic of Northern Cyprus, who consented to participate in the study. Results: Of those that did respond, only 13% of the pharmacists, 2 % of the nurses and 20% of the physicians had knowledge about ?pharmacovigilance?. Respectively %32, 12 and 54 were reported an ADR within the recent year, but only 10% of the pharmacists and 4% of physicians stated that they sent an ADR report to the concerned organization. None of the nurses and physicians reported an ADR. The common reasons for not reporting was stated as lack of knowledge of where/how to report, lack of time, ADR reporting being not mandatory, belief that it was not their responsibility, hesitation about the clinical knowledge, refraining the legal liability. Conclusion: The results show that the health professionals in Northern Cyprus have insufficient knowledge about pharmacovigilance. Therefore, it seems there is an urgent need for a training program about pharmacovigilance and ADR reporting.